Iman Ezelarab,
All-cause mortality and cardiovascular mortality were higher with febuxostat than with allopurinol. All-cause mortality and…
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
Overview of attention for article published in New England Journal of Medicine, March 2018
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
High Attention Score compared to outputs of the same age and source (89th percentile)
Mentioned by
- news
- 35 news outlets
- blogs
- 7 blogs
- policy
- 1 policy source
- 612 X users
- patent
- 3 patents
- 18 Facebook pages
- wikipedia
- 3 Wikipedia pages
- googleplus
- 2 Google+ users
- 7 Redditors
- f1000
- 1 research highlight platform
- guideline
- 6 clinical guideline sources
- podcasts
- 3 podcasts
Readers on
- mendeley
- 671 Mendeley
- citeulike
- 1 CiteULike
